# Cardea SOLOTM for Paroxysmal Atrial Fibrillation Diagnosis in ESUS Patients With Left Atrial Enlargement

> **NCT05431972** · NA · COMPLETED · sponsor: **Asan Medical Center** · enrollment: 257 (actual)

## Conditions studied

- Embolic Stroke of Undetermined Source

## Interventions

- **DEVICE:** Cardea SOLO
- **DEVICE:** 12 Lead EKG

## Key facts

- **NCT ID:** NCT05431972
- **Lead sponsor:** Asan Medical Center
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-11-01
- **Primary completion:** 2024-09-13
- **Final completion:** 2024-09-13
- **Target enrollment:** 257 (ACTUAL)
- **Last updated:** 2025-12-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05431972

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05431972, "Cardea SOLOTM for Paroxysmal Atrial Fibrillation Diagnosis in ESUS Patients With Left Atrial Enlargement". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT05431972. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*